VO2max as a longevity marker: the cohort evidence

Key takeaways

• VO2max tracks all-cause mortality across multiple large cohorts (Mandsager 2018: 122,007 adults ; Imboden 2018: 4,137 adults ; Kokkinos 2022: 750,302 US veterans ). The gradient is steep at the low end and keeps going into elite ranges.
• Pooled across a meta-analysis of 33 cohorts, each 1-MET higher cardiorespiratory fitness mapped to about 13 percent lower all-cause mortality (risk ratio 0.87) after adjustment for standard risk factors .
• The lowest-fitness group carried roughly 5x the all-cause mortality hazard of the elite-fitness group (adjusted HR 5.04) in Mandsager 2018, a larger risk than coronary artery disease, diabetes, or smoking in the same model .
• This is an association. Mendelian randomization using activity proxies is consistent with a causal contribution, but a mortality-endpoint randomized trial is not ethically runnable .
• A 37-trial meta-analysis found training raised VO2max by an average of 0.51 L/min over 6 to 13 weeks . At matched training time, higher-intensity intervals tend to add more than easy continuous work .

Skip to:

• The cohort finding: fitness tracks all-cause mortality
• The named cohort studies and what each found
• Absolute VO2max by age and sex
• Association is not causation
• What actually raises VO2max
• Training zones and the 'zone 2' conversation
• Where peptides and pharmacology fit
• The honest read

The cohort finding: fitness tracks all-cause mortality

Cardiorespiratory fitness, measured directly as VO2max or estimated from a graded exercise test, sits on a steep gradient with all-cause mortality across large cohorts. The pooled effect is large: in a meta-analysis of 33 cohorts, each 1-MET higher fitness carried about 13 percent lower all-cause mortality (risk ratio 0.87, 95 percent CI 0.84 to 0.90) . Outside of established disease and smoking, few single measurements track long-term mortality this consistently.

The signal reproduces in occupational cohorts, clinical referral populations, and general-population samples across decades. The curve is roughly continuous: there is no clean threshold where risk stops falling, and the steepest part sits between low and moderate fitness, not between high and elite.

The named cohort studies and what each found

• Mandsager 2018 (JAMA Network Open): 122,007 adults referred for treadmill testing at Cleveland Clinic. The lowest-fitness group had an adjusted all-cause mortality hazard of 5.04 (95 percent CI 4.10 to 6.20) versus the elite-fitness group (at or above 2 SD over the age- and sex-adjusted mean), a risk comparable to or greater than coronary artery disease (HR 1.29), diabetes (HR 1.40), and smoking (HR 1.41) in the same model. There was no observed upper limit of benefit .
• Imboden 2018 (J Am Coll Cardiol): 4,137 apparently healthy Ball State Adult Fitness Program adults followed a median of about 24 years. Each 1-MET higher CRF was associated with an 11.6 percent lower all-cause mortality risk after adjustment .
• Strasser and Burtscher 2018 (Front Biosci, Landmark Ed): a narrative review framing VO2max as a strong, independent predictor of all-cause and disease-specific mortality, with the physiology behind the dose-response .
• Lee et al. 2011 (Circulation): 14,345 men in the Aerobics Center Longitudinal Study. Men who maintained or improved fitness between two exams had lower mortality, and every 1-MET gain tracked with about 15 percent lower all-cause mortality. That change-over-time design is the closest the observational literature gets to a directionality argument .
• Kokkinos et al. 2022 (J Am Coll Cardiol): 750,302 US veterans, the largest CRF cohort to date. The inverse fitness-mortality dose-response replicated across age, sex, and race, with the lowest risk around 14 METs .

Absolute VO2max by age and sex

VO2max falls with age in a roughly linear way. The FRIEND registry (Fitness Registry and the Importance of Exercise National Database) gives age- and sex-specific reference percentiles from cardiopulmonary exercise tests :

• Men age 30-39: 50th percentile about 42 mL/kg/min; 90th percentile about 57 mL/kg/min.
• Men age 50-59: 50th percentile about 33 mL/kg/min; 90th percentile about 46 mL/kg/min.
• Men age 70-79: 50th percentile about 24 mL/kg/min; 90th percentile about 37 mL/kg/min.
• Women age 30-39: 50th percentile about 30 mL/kg/min; 90th percentile about 41 mL/kg/min.
• Women age 50-59: 50th percentile about 23 mL/kg/min; 90th percentile about 32 mL/kg/min.
• Women age 70-79: 50th percentile about 18 mL/kg/min; 90th percentile about 23 mL/kg/min.

Elite endurance athletes typically reach 70 to 90 mL/kg/min. The mortality gradient is steepest in the lower percentiles, where a small absolute gain buys the largest drop in risk.

Association is not causation

Cohort designs cannot prove that raising VO2max lowers mortality. Someone who runs 30 miles a week probably also sleeps better, smokes less, and carries less visceral fat, and statistical adjustment never fully removes that overlap. This is the standard confounding problem in observational epidemiology, laid out plainly by Hernan .

Mendelian randomization tries to get at direction by using genetic variants as instruments for fitness or physical activity. A genome-wide study of walking pace, used as an activity proxy, found MR estimates consistent with a causal link between faster walking and lower cardiometabolic risk . That supports direction but cannot pin down the population effect size.

A mortality-endpoint trial randomizing adults to exercise or no exercise for decades is not feasible. Follow-up would need to run for decades, control subjects will not stay sedentary that long, and no ethics board will assign people to a known-harmful comparator. So the causal case rests on Mendelian randomization, the mechanistic biology, and a cohort signal that holds across populations and decades.

What actually raises VO2max

• Sustained aerobic training near the top of your sustainable intensity. Both continuous training and interval work raise VO2max in randomized trials, though not equally.
• In Helgerud 2007, interval protocols at 90 to 95 percent of max heart rate (4x4 minutes and 15/15) raised VO2max 5.5 to 7.2 percent over 8 weeks in moderately trained men, while long slow distance and lactate-threshold work at matched total work produced no significant change .
• Across 37 trials, 6 to 13 weeks of aerobic training raised VO2max by an average of 0.51 L/min (95 percent CI 0.43 to 0.60), with a subset showing 0.8 to 0.9 L/min . From an untrained baseline that is a large relative gain; already-trained people plateau into single-digit yearly percentages.
• Mixing modalities (running plus cycling or rowing) is usually better tolerated than piling all the volume into one high-impact mode.
• Standard activity guidelines set a floor of at least 150 minutes per week of moderate or 75 minutes per week of vigorous aerobic activity for general health . That floor is a general-health minimum. VO2max gains come more from intensity and progressive overload than from any particular weekly minute count.
• A genetic ceiling is real but most adults never reach it; population data put it well above what typical training produces.

Training zones and the 'zone 2' conversation

Endurance training gets framed in zones (1 to 5 by heart rate or power) tied to the lactate thresholds. Popular 'zone 2' (roughly 60 to 70 percent of max heart rate, just under the first lactate threshold) is where trained athletes park most of their easy volume. Seiler's work on elite endurance athletes describes about 80 percent of sessions at low intensity and about 20 percent hard, the polarized distribution .

For a non-elite adult raising VO2max from baseline, the practical version is simpler: get some easy-to-moderate volume in (zones 2 to 3) and some genuinely hard intervals (zones 4 to 5) each week. Polarization tuning matters far more for racing athletes than for someone trying to move a mortality risk that is steepest at the bottom of the fitness range.

Where peptides and pharmacology fit

No FDA-approved peptide or small molecule durably raises VO2max in healthy adults. The mitochondrial-biogenesis literature has preclinical work on AMPK activators, PPARd agonists (cardarine / GW-501516, which is WADA-prohibited and carries documented preclinical carcinogenicity signals: it drove metastatic gastric cancer in a carcinogen-primed mouse model ), and ERR agonists (the SLU-PP-332 preclinical line). None has a controlled human VO2max trial behind it.

EPO (erythropoietin) and blood doping raise oxygen-carrying capacity and measured VO2max, but they are WADA-prohibited and carry real cardiovascular risk, so they are not a longevity play. Iron corrects VO2max only in people who are iron-deficient; it does nothing for VO2max in iron-replete people.

The honest read

VO2max is about as strong a single mortality correlate as observational medicine has, consistent enough to treat fitness as a real health signal rather than a vanity number. The mortality endpoint has never been proven causal by a trial and probably never will be, which is worth saying out loud but does not change what to do. Structured aerobic training raises VO2max in most adults, and nothing in a vial does it better.

For research and educational purposes only. Not medical advice.

pepSmart has not commissioned independent clinical review of this article.

More on how we write and source these pieces: Editorial process and contributor disclosure and Sourcing posture.

Spot an error? Email corrections via /about.

Sources: 16 entries, all primary canon (peer-reviewed journals and the WADA Prohibited List), last reviewed 2026-07-08.